*****SPECULATION IS WE COULD GET A SIZEABLE MOVE IN THE STOCK TODAY WITH W EASY 30% GAIN********************* SET ALERTS FOR A POSSIBLE MOVE TO ABOVE $2
AVERAGE PRICE TARGET $9 AVERAGE RECOMMENDATION buy
LEAP THERAPEUTICS INC. Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Its clinical stage programs are DKN-01 and TRX518.